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Analysis Interconnection Evolution by rpoB Genome in
Multidrug Resistant of Mycobacterium tuberculosis in Ira-
nian Isolates
S. Zakerbostanabad1,∗, F. Abdolrahimi1, A. Nour
Nematollahi 1, M. Ghazanfari 1, L.P. Titov2
1 Molecular Genetic Laboratory, Institute Pasteur Institute
of Iran, Tehran, Tehran, Iran (Islamic Republic of)
2 Department of Clinical Microbiology, Belarusian Research
for Microbiology and Epidemiology, Minsk, Minsk, Belarus
Background: This is the ﬁrst genetic biodiversity study of
M. tuberculosis in Iran. Thus, we investigated the genetic
patterns of strains isolated in the ﬁrst survey of anti-
tuberculosis drug-resistance by rpoB gene as part of the
Global Project of Anti-tuberculosis Drug Resistance Surveil-
lance (IPI, Iran).
Material and Method: A 411-bp fragment of the rpoB
gene, containing the sequence of the 81-bp rpoB fragment,
was ampliﬁed by PCR and the rpoB gene fragments of tuber-
culosis strains were sequenced using the Amersham auto
sequencer. For analysing tree evolution used method UPGMA
and Neighbour-Joining. Clinical isolates (34/163) were ana-
lyzed by using sequencing gene rpoB and genotyped by
program MEGA.
Results: The results were compared with the interna-
tional database. MDR was 14% in never treated patients and
8% in previously treated patients. Mutations in rpoB gene
and katG genes were detected in 95% and 84% of the MDR
strains, respectively. Two clusters were found to be identical
by the four different analysis methods, presumably repre-
senting cases of recent transmission of MDR tuberculosis.
The other strains are divided into 2 groups: group A - simi-
lar to the standard and Eastern strains (China, Taiwan) and
group B - strains of another genotype. They are grouped
separately on the dendrogram and became prevalent in Iran
(they are called Iranian residential strains).
Conclusion: This study gives a ﬁrst overview of the M.
tuberculosis strains circulating in Iran during the ﬁrst survey
of anti-tuberculosis drug-resistance. It may aid in the cre-




Distribution of Pulmonary Tuberculosis and TB Drug Resis-
tance in a Hospital Setting in Papua New Guinea
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Tuberculosis (TB) is increasing at alarming rates in Papua
New Guinea (PNG). WHO revealed a staggering incidence
rate of 104/100 000 population in 2004, which coincided
with a mere 20% case-detection rate. TB drug resistance
has never been investigated, however is anticipated to be
present in high proportions. This hospital-based perspec-
tive study was aimed at investigating the distribution of
pulmonary TB and TB drug resistance, with speciﬁc objec-
tives of establishing drug resistance proﬁle for this study
setting and providing a form of guideline for future drug
resistance monitoring and therapy approaches in hospi-
tal settings in PNG. Patients were recruited on routine
presentation at Modilon Hospital, Madang Province. Direct
smear microscopy was carried out followed by sputum pro-
cessing using 4% sodium hydroxide (NaOH). Culture and
drug resistance testing were performed using the BACTEC
MGIT960 Culture System. A total of 339 new TB patients
were recruited between January and December of 2006 and
53% were positive for acid-fast bacilli. Two hundred and
forty samples were cultured and 30.4% (73/240) showed
positive growth. Drug resistance testing was successfully
carried out in 69 isolates, of which 92.8% were from new
TB cases. Overall drug resistance was therefore, observed
in 17.4% (11 new cases and 1 previously treated case).
Multiple drug resistant TB (MDR-TB) was detected in 8.7%
(5 new TB cases and 1 previously treated case). Resis-
tance to at least streptomycin was the most common (75%
of all drug resistant cases) followed by resistance to at
least rifampicin (50%). This study provided the ﬁrst evi-
dence of TB drug resistance in PNG. MDR-TB alone was the
most common form of TB drug resistance observed in this
study. Madang province is rated as median risk for TB, thus




The 60 Years Battle Against Tuberculosis in Hong Kong - A
Review of the Past and a Projection Into the 21st Century
S.H. Lee
Hong Kong Tuberculosis, Chest and Heart Diseases Associa-
tion, Hong Kong, China
Background: In October 2008, the Hong Kong Tuberculo-
sis, Chest and Heart Diseases Association will be celebrating
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its 60th anniversary since its establishment in 1948. The 60th
anniversary provides an excellent opportunity to undertake
a review in the past and a projection into the future. The
review will be beneﬁcial to the participants at the Inter-
national Conference to share one another’s experience as
tuberculosis remains a common problem in many parts of
the world.
Method: The methods used include a search of the
relevant ofﬁcial reports, documents, publications about
tuberculosis control in Hong Kong and personal interviews
with professionals in the academic and private sectors.
The author’s personal experiences as former Director of
Health, Hong Kong, will greatly enhance the values of the
review.
Results: The TB notiﬁcation rate has fallen from 697.2
per 100,000 population in 1952 to 90.4 per 100,000 in 2005.
The death rate from TB fell from 168.1 per 100,000 to 4.0
over the same period. The infant mortality rate from TB has
also fallen from 3.5 per 1000 registered live births in 1952 to
zero in 2005. The average age of TB deaths has lengthened
considerably from 25 in 1952 to 74.3 in 2005. Today Hong
Kong has already well exceeded the three targets for 2005
as set out by the WHO Regional Committee for the Western
Paciﬁc which included detecting 70% of estimated TB cases,
successfully treating 85% of these cases and making DOTS
accessible to 100% population.
Conclusion: Although Hong Kong has successfully con-
trolled TB in the past, there are new challenges in
the future, because of population movement, emergence
of MDR-TB and XDR-TB, and the problem of HIV/TB
co-infection. There is a need to strengthen the surveil-
lance system and intensify our efforts, particularly on
chemotherapy and laboratory services, responding to
HIV/TB co-infection and MDR-TB. Strong partnership with all
sectors at local, regional and international levels is essential
in our ultimate success on TB control.
doi:10.1016/j.ijid.2008.05.899
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Anti-Tuberculous Drug Resistance of Mycobacterium
tuberculosis Strains Isolated from Van Region
H. Bozkurt1, R.B. Nalcacıoglu1, M.G. Kurtoglu1, R. Kesli 2,∗,
M. Berktas1
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Introduction: The study has been performed in order to
search the species distribution and the resistance rates of
mycobacteria to antituberculous agents isolateded in the
region of Van.
Materials and Method: Identiﬁcation of strains have
been carried out through the method of DNA-hybridization
(Accu Probe-Gen Probe Levder, USA- hybridization device
and Accu Probe-Gen Probe, San Diego, California, USA-
Mycobacterium tuberculosis complex identiﬁcation test) for
the mycobacterium bacilli isolated by inoculating to Löven-
stein Jensen culture, an then by means of the E test
method (AB Biodisc, Sweden), the etambutol (ETB), strep-
tomisin (SM), isoniazid (INH) and rifanpin (RIF) resistance
of the species have been searched. Middle Brook 7 H9
Broth (Difco, USA) and Middle Brook 7 H10 agar (Difco,
USA) cultures were used for anti-tuberculosis drug resistance
tests.
Results: As the result of the study, while identifying the
species of the 25 tuberculosis bacilli isolated from the dif-
ferent patients which was performed through Gen Probe
method, it was determined that all of them were Mycobac-
terium tuberculosis. However, at the susceptibility test
carried out through E Test method, resistance was deter-
mined at the rate of 4% to ETB, and 8% to RIF. In none of the
strains was resistance determined against SM and INH.
Conclusion: The study is important because of its being
the ﬁrst study performed in order to determine the anti-
tuberculous drug resistance in the province of Van.
doi:10.1016/j.ijid.2008.05.900
50.007
Study of mutations associated with isoniazid resistance in
clinical Mycobacterium tuberculosis strains from Tehran
and Isfahan province tuberculosis centers by PCR and
RFLP(1383—4)
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Republic of)
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Background: Although isoniazid is most efﬁcient in killing
the tuberculosis bacilli, resistance to this drug also devel-
ops most readily. Mutations in katG, inhA and ahpC are
responsible for isoniazid resistance in a large proportion of
tuberculosis cases. However, the frequency of these muta-
tions varies with population samples. This study provided
the ﬁrst molecular characterization of isoniazid resistance
of M. tuberculosis strains that is widely applicable for rapid
drug resistance detection.
Methods: The study was diagnostic-testing and pres-
ence of mutations in speciﬁc regions of the katG, inhA and
ahpC genes was analyzed with 32M.tuberculosis isoniazid-
resistant strains from Isfahan and Tehran. The katG
mutations in codon 315 associated with isoniazid resistance
among isoniazid resistant isolates was determined by PCR-
RFLP. In this way, 355 bp PCR products were digested by MspI
and MspA1I. Mutations in inhA and ahpC genes were detected
by sequencing
Results: Mutations in the katG 315(Ser→Thr), inhA and
ahpCwere detected in 71.9, 18.9 and 6.2% of the 32 isoniazid
resistant isolates, respectively. Mutations were not found in
one (%) of the isolates.
Discussion: The PCR-RFLP with MspI that detect katG
Ser315Thr substitution identiﬁed more isoniazid-resistant
strains with mutations at codon 315 in the katG. Elucidation
of the molecular basis of isoniazid resistance in M. tuber-
culosis has led to the development of different genotypic
approaches for the rapid detection of isoniazid resistance
in clinical isolates. The results also suggest that detection
of the Ser315Thr in the katG gene may be used as a rapid
screening method for identifying isoniazid-resistant clinical
